Sign in

Integrated DNA Technologies

@idtdna.bsky.social
76 followers 37 following 213 posts

Our vision of enabling researchers to rapidly move from the lab to life-changing advances reflects our commitment to a healthier, brighter future for all. 🧬 idtdna.com Privacy Notice: idtb.io/privacy

PostsRepliesMedia
Integrated DNA Technologies @idtdna.bsky.social · 01/10/2026
Avoid dead-end workflows when your fragment request hits a limit. With IDT and Ansa, there’s a better path forward. ⏩ Our “No Loose Ends” workflow helps guide complex designs beyond fragment fit—toward fully assembled clonal genes, without losing momentum. 🧬 Learn more here: idtb.io/07t7jr
000
Integrated DNA Technologies @idtdna.bsky.social · 29/09/2026
#CRISPR/Cas9 transformed #genomeediting, but it's no longer the only option. Explore current approaches and key considerations to choosing the right tool with IDT's Mollie Schubert and Aldevron's Loren Schoch in SEQanswers: ow.ly/Flwb50ZFHPe
001
Integrated DNA Technologies @idtdna.bsky.social · 28/09/2026
Big ideas, challenging questions, and meaningful scientific exchange.💥 Our Advanced Genomics Symposium brought together leading voices in genomics to explore the next frontiers of #CRISPR, #AI, and #DNAsynthesis. Thanks to all who joined us in London!🧬
000
Integrated DNA Technologies @idtdna.bsky.social · 24/09/2026
400 institutions served. Up to 50kb. 97% fulfillment. 42x increase in complexity. IDT+Ansa is a partnership that pushes beyond the traditional 7kb synthesis ceiling, and resets standards. Get greater design freedom here: idtb.io/07t7jr
000
Integrated DNA Technologies @idtdna.bsky.social · 23/09/2026
If you registered with IDT for the #iGEM Competition, you have until October 12 to order with us! Be sure to snag your 40kb of gBlocks™ Gene Fragments or equivalent value of IDT products, and take advantage of our free resources: idtb.io/79d14nf3
000
Integrated DNA Technologies @idtdna.bsky.social · 21/09/2026
Struggling with difficult-to-maintain #DNAconstructs? 🧬 pStable™ vectors offer a stability-focused approach that helps support propagation of large, repetitive, toxic, and complex sequences while allowing researchers to boost plasmid yield when needed. Read more in our blog: idtb.io/v4lc2k17
000
Integrated DNA Technologies @idtdna.bsky.social · 20/09/2026
📣LAST CALL iGEM PARTICIPANTS! Tomorrow is the final day to register with IDT! Take advantage of 40kb of gBlocks™ Gene Fragments or equivalent value of IDT products for your project. Learn more: idtb.io/n67bfxr4
000
Integrated DNA Technologies @idtdna.bsky.social · 17/09/2026
It's the last day of #GEAR26! Don't miss your chance to visit the IDT table to discover our CRISPR portfolio, including our new Cas9 mRNA solution and off-target analysis services. See you soon!
000
Integrated DNA Technologies @idtdna.bsky.social · 16/09/2026
We’re excited to announce that we’re partnering with Aldevron to launch a new S.p. Cas9 mRNA solution—offering researchers and therapeutic developers a game-changing approach to gene editing.🙌 Read more here: idtb.io/trqtytv7
000
Integrated DNA Technologies @idtdna.bsky.social · 13/09/2026
We’ve made it to Stockholm for #ECP2026! Don’t forget to stop by booth #323 to discover how our Archer™ portfolio supports blood cancer applications like liquid biopsy and hematological malignancy research. See you soon! 👋
000
Integrated DNA Technologies @idtdna.bsky.social · 10/09/2026
The next generation of #MRD and #MCED programs demand unprecedented #DNAcomplexity. Learn how we're helping researchers overcome synthesis limitations with expanded capabilities designed to support sophisticated assay designs and accelerate innovation in #cancerresearch: ow.ly/CZKR50ZIrwF
000
Integrated DNA Technologies @idtdna.bsky.social · 09/09/2026
#GEAR26 is almost here! Remember to visit the IDT table to explore our #CRISPR portfolio, including our new #Cas9 mRNA solution and #off-targetanalysis services. Also, check out posters from IDT scientists to see our CRISPR products in action—details below. Learn more here: ow.ly/8SXS50ZIiCt
000
Integrated DNA Technologies @idtdna.bsky.social · 08/09/2026
ICYMI: We’re expanding our collaboration with Ansa Biotechnologies to provide broader global access to long and complex #syntheticDNA through a streamlined ordering experience. Over 400 institutions across 33 countries have benefitted from our partnership so far! Learn more: idtb.io/07t7jr
000
Integrated DNA Technologies @idtdna.bsky.social · 04/09/2026
We're excited to connect at #ECP2026! Visit our trusted experts at booth #323 to explore our portfolio of blood cancer research solutions and discover how Archer™ technologies support liquid biopsy and hematological malignancy research. Learn more: www.espcongress.org
000
Integrated DNA Technologies @idtdna.bsky.social · 03/09/2026
Excited to attend GEAR for the first time! Visit the IDT table to explore our CRISPR portfolio, including our new Cas9 mRNA solution and off-target analysis services. Also, check out posters from IDT scientists to see our CRISPR products in action. Learn more here: ow.ly/nX1R50ZIioR
000
Integrated DNA Technologies @idtdna.bsky.social · 02/09/2026
🥳 We’re celebrating our anniversary! Nearly four decades ago, Dr. Joseph Walder founded IDT with a vision to make genomics more accessible and advance scientific discovery. 🧬 Thank you to everyone who has been part of the journey. Learn more: ow.ly/Qfsp50ZHEnW
000
Integrated DNA Technologies @idtdna.bsky.social · 01/09/2026
🧬Researchers are pushing #DNAdesign further than ever, and access shouldn't be the bottleneck. That’s why we’re expanding our collaboration with Ansa Biotechnologies to provide broader global access to long and complex #syntheticDNA through a streamlined ordering experience: idtb.io/1c8wxg71
000
Integrated DNA Technologies @idtdna.bsky.social · 31/08/2026
Biology is pushing DNA further than ever before. Learn how the IDT + Ansa collaboration is helping expand access to complex, sequence-verified DNA in our latest blog: idtb.io/1xmarppv
000
Integrated DNA Technologies @idtdna.bsky.social · 28/08/2026
As gene editing programs advance, confidence in off-target assessment is critical. New research highlights how UNCOVERseq™ delivered the strongest combination of sensitivity and precision among evaluated methods. Learn more in CRISPR Medicine News: ow.ly/A8bn50ZGx5N
010
Integrated DNA Technologies @idtdna.bsky.social · 26/08/2026
#CRISPR/Cas9 transformed #genomeediting, but it's no longer the only option. Explore current approaches and key considerations to choosing the right tool with IDT's Mollie Schubert and Aldevron's Loren Schoch in SEQanswers: ow.ly/Flwb50ZFHPe
000
Integrated DNA Technologies @idtdna.bsky.social · 24/08/2026
Building confidence in #geneediting starts with better off-target assessment. A recent Nature Communications study showed UNCOVERseq™ delivered the strongest combined sensitivity and precision among evaluated methods. Learn more from Gavin Kurgan in GenomeWeb: ow.ly/gxp950ZERuX
000
Integrated DNA Technologies @idtdna.bsky.social · 20/08/2026
We are proud to announce that we’re expanding our #DNAsynthesis capabilities to support needs across yield, complexity, and scale—from rapid production of high-diversity designs in early development, to dependable manufacturing for larger, longer-term programs. Read more: idtb.io/3yk3haww
000
Integrated DNA Technologies @idtdna.bsky.social · 18/08/2026
The future of gene editing depends on understanding what happens beyond the target site. Learn how UNCOVERseq™ is helping advance precision #geneediting and support #translationalresearch and #therapeuticdevelopment in our latest blog: idtb.io/8wqtl7yy
000
Integrated DNA Technologies @idtdna.bsky.social · 11/08/2026
IDT is defining the standard for safer #genomeediting.🧬 We’re delighted to share a peer-reviewed Nature Communications study—establishing that IDT’s UNCOVERseq™ delivered the strongest combined sensitivity and precision among evaluated CRISPR off-target nomination methods: idtb.io/dn5gelwl
010
Integrated DNA Technologies @idtdna.bsky.social · 10/08/2026
We’ve got an exciting line up of posters at #CSHL2026! This is your chance to learn more about our #CRISPR portfolio from IDT scientists. Take a look below to see what’s up for discussion—see you there: meetings.cshl.edu/meetings.aspx?mee… #CSHL #genetherapy #genomeediting
000
Integrated DNA Technologies @idtdna.bsky.social · 06/08/2026
There’s still time to register for our next webinar! Join us to discover how targeted sequencing workflows are helping researchers generate high-quality #genomicdata, strengthen outbreak investigations, and better understand pathogen transmission: ow.ly/ov5P50Zv4TM
111
Integrated DNA Technologies @idtdna.bsky.social · 04/08/2026
We are thrilled to host a workshop at #CSHL2026! Learn more about IDT’s CRISPR toolbox, how we support all workflows from early discovery to translational research, and how our solutions can accelerate genome editing programs from discovery to IND-enabling studies: go.idtdna.com/cshl2026
000
Integrated DNA Technologies @idtdna.bsky.social · 31/07/2026
Our upcoming webinar with GenomeWeb will explore targeted sequencing strategies with insights into assay design workflow efficiency, and data comparability across platforms. Register here: event.on24.com/wcc/r/5400914/DCB0D9…
000
Integrated DNA Technologies @idtdna.bsky.social · 29/07/2026
Boost your edits, fast-track your breakthrough✨ Our Alt-R™ HDR Enhancer Protein improves HDR efficiency across established and primary cell types. Matthew Porteus, CSO of Kamau Therapeutics, talks about his experience with the enhancer protein below—check it out! ow.ly/6twB50ZupLK
000
Integrated DNA Technologies @idtdna.bsky.social · 22/07/2026
IDT & Ansa Biotechnologies are here to help you push boundaries with longer DNA constructs, challenging motifs, and higher complexity backed by a partner trusted for consistency & accuracy. Together, we empower researchers to confidently tackle their most complex projects: ow.ly/s5TN50ZqTaB
000
Reposted by Integrated DNA Technologies
Ansa Biotechnologies @ansabio.bsky.social · 16/07/2026
𝗛𝗲𝗹𝗽𝗶𝗻𝗴 𝘀𝘆𝗻𝘁𝗵𝗲𝘀𝗶𝘀 𝗸𝗲𝗲𝗽 𝗽𝗮𝗰𝗲 𝘄𝗶𝘁𝗵 𝗱𝗶𝘀𝗰𝗼𝘃𝗲𝗿𝘆: Take a peek inside the partnership with @idtdna.bsky.social in this article by Christopher Vakulskas, who truly put us through our paces. bit.ly/3R1cECC
bit.ly
Helping synthesis keep pace with discovery: Inside the IDT-Ansa partnership
The pace of synthetic biology is accelerating—and with it, the complexity of the DNA constructs researchers are being asked to design, build, and validate. Longer constructs, difficult motifs, and inc...
011
Integrated DNA Technologies @idtdna.bsky.social · 16/07/2026
Multiplex qPCR has become a go-to approach for researchers looking to maximize sample value while improving throughput and reducing costs. However, unlocking its full potential requires thoughtful assay design, optimization, and validation. Ashlee Strubberg shares insights: ow.ly/Fvso50ZolCt
000
Integrated DNA Technologies @idtdna.bsky.social · 14/07/2026
IDT's Steven Henck and Scott McCuine explain that making #MCED and #MRD a reality requires overcoming hurdles in sample quality, assay sensitivity, workflow complexity, and regulatory and market readiness to enable broad adoption: www.nature.com/articles/d42473-026-…
000
Integrated DNA Technologies @idtdna.bsky.social · 13/07/2026
IDT's Rolf Turk shares perspectives on how continuous improvement, strategic collaboration, and innovation can help accelerate scientific discovery and advance the future of life sciences: ow.ly/20uY50Zn0jC
ow.ly
Driving Innovation Through Continuous Improvement in Life Sciences
Driving Innovation Through Continuous Improvement in Life Sciences By Rolf Turk, Senior Director - Innovation Programs, Integrated DNA Technologies - The beauty of science lies in an unrelentless quest towards discovery, innovation and application.
000
Integrated DNA Technologies @idtdna.bsky.social · 09/07/2026
As CRISPR-based research and therapies continue to advance, understanding and minimizing off-target effects is critical for ensuring reliable, reproducible, and safe genome editing outcomes. Read more: idtb.io/tsi4wm5a
000
Integrated DNA Technologies @idtdna.bsky.social · 08/07/2026
IDT’s trusted expertise 🤝 Ansa’s enzymatic DNA synthesis platform Push boundaries with DNA constructs up to 50kb, challenging motifs, and higher complexity backed by a partner trusted for consistency and accuracy. We empower researchers to tackle their most complex projects: idtb.io/07t7jr
000
Integrated DNA Technologies @idtdna.bsky.social · 06/07/2026
New, free app note!📣 We collaborated with Mission Bio to highlight how Nechama Kalter & the Ayal Hendel lab are characterizing CRISPR edits in primary T cells. 🔗Download it here: ow.ly/h6mj50Z8QEI
000
Integrated DNA Technologies @idtdna.bsky.social · 01/07/2026
The revolutionary potential of CRISPR-Cas gene editing is undeniable, but moving from the bench to the bedside requires navigating a complex landscape of off-target assessments. 🔗 Read more in our latest blog: idtb.io/m2cuocne
010
Integrated DNA Technologies @idtdna.bsky.social · 24/06/2026
As #clinicalNGS continues its expansion, labs face pressure to balance innovation with compliance. IDT's Ashleigh Dawley explores how labs can build scalable, audit-ready workflows—from validating #bioinformatics platforms to selecting the right reagents and partners: ow.ly/qaQE50Z9mVj
000
Integrated DNA Technologies @idtdna.bsky.social · 18/06/2026
Boost your edits and fast-track your breakthrough. 🚀 Learn how our Alt-R™ HDR Enhancer Protein improves CRISPR knock-in efficiency by promoting HDR pathway precision—seamlessly integrated into workflows. Discover what’s possible here: idtb.io/qvbm5v
000
Integrated DNA Technologies @idtdna.bsky.social · 17/06/2026
IDT LOVES SUPPORTING iGEM! We offer up to 40kb of gBlocks™ Gene Fragments or equivalent value of IDT products—but only to registered teams! Make sure you register with us by September 21. Learn more here: idtb.io/79d14nf3
000
Integrated DNA Technologies @idtdna.bsky.social · 14/06/2026
#ESHG is in full swing, and we’re having a blast! 🙌 Remember to stop by booth #622—our trusted experts are ready to discuss how our #NGSsolutions can support your research, from amplification to hybrid capture and automation-friendly library prep. See you soon! 👋
000
Integrated DNA Technologies @idtdna.bsky.social · 11/06/2026
MCED and MRD research are redefining what’s possible in #cancerresearch. The challenge? Identifying one fragment of tumor DNA among millions—and doing it with consistency, at scale, in research workflows. Read more from Steven Henck and Scott McCuine: ow.ly/znM750ZauXH
000
Integrated DNA Technologies @idtdna.bsky.social · 09/06/2026
As #clinicalNGS continues its expansion, labs face pressure to balance innovation with compliance. IDT's Ashleigh Dawley explores how labs can build scalable, audit-ready workflows—from validating #bioinformatics platforms to selecting the right reagents and partners: ow.ly/qaQE50Z9mVj
000
Integrated DNA Technologies @idtdna.bsky.social · 08/06/2026
New, free app note!📣 We collaborated with Mission Bio to highlight how Nechama Kalter & the Ayal Hendel lab are characterizing CRISPR edits in primary T cells. 🔗Download it here: ow.ly/h6mj50Z8QEI
000
Integrated DNA Technologies @idtdna.bsky.social · 05/06/2026
We’re a week away from #ESHG2026! 🙌 Join IDT experts at booth #622 to explore how our #NGS solutions can support reproducible, scalable, and automation‑ready workflows across your research. Discover how we can help your lab to move from discovery to insight: 2026.eshg.org
010
Integrated DNA Technologies @idtdna.bsky.social · 04/06/2026
As #CRISPR programs move closer to the clinic, confidence in gene editing safety becomes just as critical as editing efficiency. Our CRISPR Off-target Analysis Services are designed to help you identify and prioritize off-target edits early—so you can advance with clarity: idtb.io/cgov2wdq
000
Integrated DNA Technologies @idtdna.bsky.social · 01/06/2026
We’re proud to unveil our latest partnership with Illumina! 🤝 This collaboration will enable an integrated, end-to-end solution for somatic #oncologyresearch by combining Illumina’s DRAGEN™ secondary analysis with IDT’s xGen™ FFPE and cfDNA workflows. Read more: idtb.io/vpoxzw27
000
Integrated DNA Technologies @idtdna.bsky.social · 28/05/2026
In recognition of National Cancer Research Month, we’re highlighting how MRD assessment and MCED are transforming #cancercare strategies. Learn more about how IDT’s advanced #NGS solutions are powering the research behind this progress: idtb.io/xtkf2o #cancerresearch #oncologyresearch
000
Integrated DNA Technologies @idtdna.bsky.social · 26/05/2026
ICYMI: The potential of CRISPR-Cas gene editing is undeniable, but moving from the design to delivery requires navigating off-target assessments. 🔗 Read more in our latest blog: idtb.io/qnfzlpic #offtargetassessment #CRISPRgeneediting
010